$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| DIRECTOR/PDMR SHAREHOLDING | 26 Sep 2016 |
| DIRECTOR DECLARATION | 22 Sep 2016 |
| TOTAL VOTING RIGHTS | 01 Sep 2016 |
| ASTRAZENECA COMPLETES ASPEN AGREEMENT | 01 Sep 2016 |
| AZ TO SELL ANTIBIOTICS BUSINESS TO PFIZER | 24 Aug 2016 |
| DIRECTOR DECLARATION | 18 Aug 2016 |
| ASTRAZENECA COMPLETES AGREEMENT WITH LEO PHARMA | 16 Aug 2016 |
| ASTRAZENECA ANNOUNCES INVESTMENT IN MODERNA | 10 Aug 2016 |
| ASTRAZENECA UPDATE ON SELUMETINIB PHASE III TRIAL | 09 Aug 2016 |
| DIRECTOR/PDMR SHAREHOLDING | 01 Aug 2016 |
| TOTAL VOTING RIGHTS | 01 Aug 2016 |
| AZN: H1 2016 RESULTS | 28 Jul 2016 |
| NOTICE OF RESULTS | 27 Jul 2016 |
| QTERN (SAXA/DAPA) EU APPROVED FOR TYPE-2 DIABETES | 19 Jul 2016 |
| TAGRISSO MET PRIMARY ENDPOINT IN PHASE III TRIAL | 18 Jul 2016 |
| TOTAL VOTING RIGHTS | 01 Jul 2016 |
| AZ ENTERS LICENSING AGREEMENTS WITH LEO PHARMA | 01 Jul 2016 |
| ZAVICEFTA APPROVED IN EU | 28 Jun 2016 |
| ASTRAZENECA UPDATES ON FLUMIST VACCINE IN THE US | 23 Jun 2016 |
| DIRECTOR/PDMR SHAREHOLDING | 14 Jun 2016 |
